Euro Biotechnology

UK’s Heptares Therapeutics and Paul Scherrer Institute spinoff leadXpro will collaborate to find new approaches for the determination of high-res X-ray structures of G protein-coupled receptors to find new drugs.

UK’s Heptares Therapeutics and Paul Scherrer Institute spinoff leadXpro will collaborate to find new approaches for the determination of high-res X-ray structures of G protein-coupled receptors to find new drugs.

Nordic Nanovector has teamed up with Areva Med to develop a treatment for leukaemia. The compound in question is a lead-212 conjugated anti-CD37 antibody.

A programme offering graduates and students the chance to start their own businesses has secured another three years funding.

After the British people voted in favour of leaving the European Union, the industry is grappling with the profound impact this will likely have on the economy, research and politics. Representatives from biotech industry, research and policits have expressed their concerns and hopes on the upcoming Brexit.

In the wake of the electorate’s decision to leave the EU, Professor David Bailey has some words of advice for the UK’s business owners.

According to analysis of the Teaching Excellence Framework (TEF), Aston is second best in the UK for teaching quality.

TxCell has jumped on its option for a licensing agreement with the Weizmann Institute of Science’s tech transfer arm after it was granted a far-reaching patent for redirected, genetically engineered T regulatory cells by the EPO.

Circassia suffered a severe blow when its cat allergy immunotherapy failed to outcompete the placebo in a Phase III trial. The company’s shares, listed in London, plunged to a third of its previous value.

The Financial Times has named an Aston University Masters in Finance programme among the best in the world.